Is Humana Stock a Good Investment?
Humana Investment Advice | HUM |
- Examine Humana's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Humana's leadership team and their track record. Good management can help Humana navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact Humana's business and its evolving consumer preferences.
- Compare Humana's performance and market position to its competitors. Analyze how Humana is positioned in terms of product offerings, innovation, and market share.
- Check if Humana pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Humana's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Humana Inc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Humana Inc is a good investment.
Sell | Buy |
Strong Hold
Examine Humana Stock
Researching Humana's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The fund retains all of the assets under management (AUM) in different types of exotic instruments. Humana Inc last dividend was 3.54 per share.
To determine if Humana is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Humana's research are outlined below:
| Humana Inc generated a negative expected return over the last 90 days | |
| Humana Inc has high historical volatility and very poor performance | |
| Over 95.0% of the company shares are owned by institutional investors | |
| On 25th of October 2024 Humana paid $ 0.885 per share dividend to its current shareholders | |
| Latest headline from newsweek.com: I abandoned my American Dream because I wasnt white. Then reality hit me | |
| The fund retains all of the assets under management (AUM) in different types of exotic instruments |
Humana uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Humana Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Humana's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 24th of April 2024 Upcoming Quarterly Report | View | |
| 7th of August 2024 Next Financial Report | View | |
| 31st of March 2024 Next Fiscal Quarter End | View | |
| 23rd of January 2025 Next Fiscal Year End | View | |
| 31st of December 2023 Last Quarter Report | View | |
| 31st of December 2023 Last Financial Announcement | View |
Humana's market capitalization trends
The company currently falls under 'Large-Cap' category with a total capitalization of 35.9 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Humana's market, we take the total number of its shares issued and multiply it by Humana's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Humana's profitablity analysis
The company has Net Profit Margin of 0.01 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.03 %, which entails that for every 100 dollars of revenue, it generated $0.03 of operating income.Determining Humana's profitability involves analyzing its financial statements and using various financial metrics to determine if Humana is a good buy. For example, gross profit margin measures Humana's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Humana's profitability and make more informed investment decisions.
The data published in Humana's official financial statements typically reflect Humana's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Humana's quantitative information. For example, before you start analyzing numbers published by Humana accountants, it's essential to understand Humana's liquidity, profitability, and earnings quality within the context of the Health Care Providers & Services space in which it operates.
Evaluate Humana's management efficiency
Humana Inc has Return on Asset of 0.0401 % which means that on every $100 spent on assets, it made $0.0401 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0784 %, implying that it generated $0.0784 on every 100 dollars invested. Humana's management efficiency ratios could be used to measure how well Humana manages its routine affairs as well as how well it operates its assets and liabilities.Humana Inc benefits from a management team that prioritizes both innovation and efficiency. We analyze these priorities to gauge the stock's future performance.
Dividend Yield 0.0119 | Forward Dividend Yield 0.0119 | Forward Dividend Rate 3.54 | Beta 0.52 |
Institutional Etf Holders for Humana
Have you ever been surprised when a price of an equity instrument such as Humana is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Humana Inc backward and forwards among themselves. Humana's institutional investor refers to the entity that pools money to purchase Humana's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| NQGCX | Nuveen Nwq Global | Mutual Fund | World Large-Stock Value | |
| JAGLX | Janus Global Life | Mutual Fund | Health | |
| GPTUX | Guidepath Tactical Allocation | Mutual Fund | Tactical Allocation | |
| GSSFX | Gotham Short Strategies | Mutual Fund | Trading--Inverse Equity | |
| VPRAX | Voya T Rowe | Mutual Fund | Allocation--50% to 70% Equity | |
| HLGE | Hartford Longevity Economy | Etf | Mid-Cap Blend | |
| PHSZX | Prudential Health Sciences | Mutual Fund | Health | |
| ACWF | IShares | Etf | US Etf |
Basic technical analysis of Humana Etf
As of the 24th of November, Humana retains the Standard Deviation of 3.17, risk adjusted performance of (0.04), and Market Risk Adjusted Performance of (0.13). Humana technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the entity's future prices. Please check out Humana Inc variance and potential upside to decide if Humana is priced fairly, providing market reflects its last-minute price of 298.11 per share.Humana's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Humana insiders, such as employees or executives, is commonly permitted as long as it does not rely on Humana's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Humana insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Raquel Bono over two months ago Acquisition by Raquel Bono of tradable shares of Humana subject to Rule 16b-3 | ||
Renaudin George Ii over two months ago Acquisition by Renaudin George Ii of 1241 shares of Humana subject to Rule 16b-3 |
Humana's Outstanding Corporate Bonds
Humana issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Humana Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Humana bonds can be classified according to their maturity, which is the date when Humana Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| HUMANA INC 395 Corp BondUS444859BF87 | View | |
| HUMANA INC 48 Corp BondUS444859BG60 | View | |
| HUMANA INC 495 Corp BondUS444859BE13 | View | |
| HUMANA INC 4625 Corp BondUS444859BB73 | View | |
| US444859BM39 Corp BondUS444859BM39 | View | |
| US444859BL55 Corp BondUS444859BL55 | View | |
| US444859BN12 Corp BondUS444859BN12 | View | |
| US444859BK72 Corp BondUS444859BK72 | View |
Understand Humana's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Humana's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.13) | |||
| Mean Deviation | 2.02 | |||
| Coefficient Of Variation | (1,523) | |||
| Standard Deviation | 3.17 | |||
| Variance | 10.07 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (0.14) | |||
| Maximum Drawdown | 14.35 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 3.69 | |||
| Skewness | (0.75) | |||
| Kurtosis | 5.85 |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.13) | |||
| Mean Deviation | 2.02 | |||
| Coefficient Of Variation | (1,523) | |||
| Standard Deviation | 3.17 | |||
| Variance | 10.07 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (0.14) | |||
| Maximum Drawdown | 14.35 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 3.69 | |||
| Skewness | (0.75) | |||
| Kurtosis | 5.85 |
Consider Humana's intraday indicators
Humana intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Humana etf daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Humana time-series forecasting models is one of many Humana's etf analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Humana's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Humana Etf media impact
Far too much social signal, news, headlines, and media speculation about Humana that are available to investors today. That information is available publicly through Humana media outlets and privately through word of mouth or via Humana internal channels. However, regardless of the origin, that massive amount of Humana data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Humana news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Humana relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Humana's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Humana alpha.
Humana Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Humana can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Other Information on Investing in Humana Etf
Humana financial ratios help investors to determine whether Humana Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humana with respect to the benefits of owning Humana security.